Risk-factor analysis and predictive-model development of acute kidney injury in inpatients administered cefoperazone-sulbactam sodium and mezlocillin-sulbactam sodium: a single-center retrospective study

Objective: Acute kidney injury (AKI) is a common adverse reaction observed with the clinical use of cefoperazone-sulbactam sodium and mezlocillin-sulbactam sodium. Based upon real-world data, we will herein determine the risk factors associated with AKI in inpatients after receipt of these antimicro...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Ruiqiu, Gao, Liming, Chen, Ping, Liu, Weiguo, Huang, Xin, Li, Xiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10286859/
https://www.ncbi.nlm.nih.gov/pubmed/37361226
http://dx.doi.org/10.3389/fphar.2023.1170987

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10286859/
https://www.ncbi.nlm.nih.gov/pubmed/37361226
http://dx.doi.org/10.3389/fphar.2023.1170987

Ejemplares similares